Cytrx Corp (NASDAQ:CYTR)

Winningtrends (42.40) Submitted: 2/19/2007 2:17:15 PM : Start Price: $26.08 CYTR Score: -83.10

Has a lock on validated, cutting edge technology.

kason777 (43.22) Submitted: 2/16/2007 1:20:59 PM : Start Price: $24.92 CYTR Score: -82.54

this could work out to be a wonder drug for numerous diseases

nackless (< 20) Submitted: 2/16/2007 9:26:29 AM : Start Price: $24.92 CYTR Score: -82.56

I like the fact that 1 percent of all royalties from arimoclomol will go to charities

mutantninjaturtl (76.43) Submitted: 2/6/2007 1:13:57 AM : Start Price: $18.23 CYTR Score: -77.79

Cawabonga!!!!

ehbjeb (< 20) Submitted: 2/5/2007 3:45:13 PM : Start Price: $17.55 CYTR Score: -77.24

genetic alteration techniques

MotleyCYTR0100 (< 20) Submitted: 2/4/2007 12:52:59 PM : Start Price: $17.98 CYTR Score: -77.71

(1) It says a trial of Clinical trial is on 3rd phase will become available in the early 2007
(2) Options to purchase technologies from a Bostob research hospital

martinlemalin (< 20) Submitted: 2/1/2007 12:01:23 AM : Start Price: $18.10 CYTR Score: -78.21

.. CYTR packs a lot of power and is affordable.

jsjjjs (< 20) Submitted: 1/29/2007 2:27:50 PM : Start Price: $15.34 CYTR Score: -76.30

CYTR will have the same future as RNAI.

IndexTrojan (33.56) Submitted: 1/23/2007 5:57:29 PM : Start Price: $14.42 CYTR Score: -74.15

Could earn orphan status on its obesity drug.

grampa9 (< 20) Submitted: 1/13/2007 10:24:17 AM : Start Price: $15.34 CYTR Score: -75.51

This is a pure gamble. The company is at the cutting edge of both pure and applied research into genetic manipulation. Its major recommendation is the individuals it has on board, particularly in the subfield of research into DNAi. I approach it as one would the idea of buying land on the far fringes of an urban area in anticipation of growth. It will take at least 10-20 years to determine success or failure.

AUSS1E (< 20) Submitted: 1/12/2007 8:44:33 PM : Start Price: $15.34 CYTR Score: -75.51

Good financials. Good bargain.

pralden (47.36) Submitted: 12/10/2006 2:08:49 AM : Start Price: $11.66 CYTR Score: -69.55

CytRx is in the final stages of testing the efficacy of Arimoclomol, the first drug to show promise in combating ALS (Lou Gerig's Disease). They have fast track marketing status in the European Union and a new funding to promote the drug. Furthermore, they are in the process of seeking a partnership or creating a subsidiary in regards to their newly developed RNAi program. They have some the best scientist working on their team, including a Nobel Laureate and discoverer of RNAi.